Danlin Xu
Impact in
- Immunology top 5%
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Psoriasis: Treatment and Pathogenesis
- Immunotherapy and Immune Responses
- Genetics top 2%
- Diabetes and associated disorders
Papers in
-
- RNA Interference and Gene Delivery 2
- Glycosylation and Glycoproteins Research 1
-
- Monoclonal and Polyclonal Antibodies Research 4
- Co-authors
- Robert A. Zivin (8 shared papers)Jeffrey A. Bluestone (7 shared papers)Julie Auger (4 shared papers)David Donaldson (1 shared paper)Lesley Taylor (1 shared paper)David M. Harlan (1 shared paper)Kevan C. Herold (1 shared paper)William Hagopian (1 shared paper)
- Journals
- Transplantation (3 papers)Neuromuscular Disorders (1 paper)Cellular Immunology (1 paper)Growth Factors (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- United StatesChinaPoland
In The Last Decade
Danlin Xu
15 papers receiving 1.7k citations
Danlin Xu's Hit Papers
Peers
Comparison fields: 5 of 72
- Immunology 781
- Genetics 939
- Endocrinology, Diabetes and Metabolism 504
- Transplantation 36
- Surgery 569
Countries citing papers authored by Danlin Xu
This map shows the geographic impact of Danlin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danlin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danlin Xu more than expected).
Fields of papers citing papers by Danlin Xu
This network shows the impact of papers produced by Danlin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danlin Xu. The network helps show where Danlin Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Danlin Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes Mellitus Hit paper breakdown → | 2002 | 908 |
| 2 | 2000 | 179 | |
| 3 | 2015 | 165 | |
| 4 | 1999 | 140 | |
| 5 | 1994 | 132 | |
| 6 | Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial. | 2002 | 98 |
| 7 | 1994 | 50 | |
| 8 | 1998 | 30 | |
| 9 | 2006 | 24 | |
| 10 | 1990 | 7 | |
| 11 | 2016 | 6 | |
| 12 | 2013 | 4 | |
| 13 | 2023 | 4 | |
| 14 | 1994 | 3 | |
| 15 | 2016 | 3 | |
| 16 | 2025 | 0 | |
| 17 | 2021 | 0 | |
| 18 | 2025 | 0 |
About Danlin Xu
Danlin Xu is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Immunology, Infectious Diseases and Organic Chemistry, having authored 18 papers that have together received 1.8k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (4 papers), Organic and Inorganic Chemical Reactions (2 papers), T-cell and B-cell Immunology (2 papers), RNA Interference and Gene Delivery (2 papers), Asthma and respiratory diseases (2 papers), Glycosylation and Glycoproteins Research (1 paper), Diabetes and associated disorders (1 paper) and Inhalation and Respiratory Drug Delivery (1 paper). The work is most often cited by research in Immunology (781 citations), Genetics (939 citations), Endocrinology, Diabetes and Metabolism (504 citations), Transplantation (36 citations) and Surgery (569 citations). Danlin Xu has collaborated with scholars based in United States, China and Poland. Frequent co-authors include Robert A. Zivin, Jeffrey A. Bluestone, Julie Auger, David Donaldson, Lesley Taylor, David M. Harlan, Kevan C. Herold, William Hagopian, Stephen E. Gitelman and Linda K. Jolliffe. Their work appears in journals such as Transplantation, Neuromuscular Disorders, Cellular Immunology, Growth Factors and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.